Biochemistry · Nitrogen Metabolism

The Urea Cycle

Your liver is running a 5-step relay race 24/7 to keep ammonia from poisoning your brain. Every enzyme is a baton. Drop one baton, the whole team dies.

Clinical Hook

You're covering the NICU. A 2-day-old male is irritable, not eating, and mom says he's been "acting weird" since she started breastfeeding. Ammonia comes back at 920 umol/L (normal is under 35).

He is actively herniating. The attending turns to you.

What organ is failing him right now?

5 Steps. One Baton. Click Each Enzyme.

Tap each step to see the full reaction. Purple = mitochondria. Blue = cytoplasm.

Mitochondria Cytoplasm
Mitochondria
1
CPS ICarbamoyl Phosphate Synthetase I. Sits in the mitochondrial matrix. The RATE-LIMITING enzyme of the whole cycle.  · Carbamoyl Phosphate Synthetase I
NH3 + CO2 + 2 ATP → Carbamoyl Phosphate
Rate-limiting step of the entire cycle.

Captures free ammonia (the poison) and converts it into carbamoyl phosphate. Needs 2 ATP because this reaction is basically forcing ammonia into a non-toxic form by brute energy force.

Why NAG activates CPS I: N-acetylglutamate is made from glutamate + acetyl-CoA. When amino acid catabolism ramps up, glutamate floods the mitochondria. NAG is synthesized. NAG binds CPS I and says: "We have too much ammonia coming in, turn up the cycle." It's the system's ammonia sensor.
Board rule: NAG activates CPS I. Not NAD. Not NADH. NAG.
2
OTCOrnithine Transcarbamylase. Also mitochondrial. The most common urea cycle enzyme defect. X-linked recessive.  · Ornithine Transcarbamylase 🔑OTC = Often The Culprit. Most common defect, X-linked, elevated Orotic acid.
Ornithine + Carbamoyl Phosphate → Citrulline
Combines ornithine with carbamoyl phosphate to make citrulline.

Citrulline is the molecule that exits the mitochondria to continue the cycle in the cytoplasm. Think of citrulline as the baton handed off to the cytoplasm team.

Board trap: OTC deficiency causes elevated orotic acid in the urine. When OTC is blocked, carbamoyl phosphate builds up in the mitochondria. It spills over into the pyrimidine synthesis pathway (carbamoyl phosphate → orotic acid). CPS I deficiency does NOT cause elevated orotic acid because the bottleneck is earlier.
Cytoplasm
3
AS SynthetaseArgininosuccinate Synthetase. In the cytoplasm. Plugs in the second nitrogen from aspartate.  · Argininosuccinate Synthetase
Citrulline + Aspartate → Argininosuccinate
Here is where the second nitrogen enters.

Aspartate donates the second nitrogen atom that will end up in urea. The first came from ammonia (step 1). This is why the urea formula is: (NH2)2CO. Two nitrogens, each sourced differently.

Think of aspartate as the second runner who shows up mid-relay with the extra cargo.
4
AS LyaseArgininosuccinate Lyase. Cleaves argininosuccinate. Deficiency causes argininosuccinic acid in the urine.  · Argininosuccinate Lyase
Argininosuccinate → Arginine + Fumarate
Splits argininosuccinate. This step generates fumarate.

Fumarate enters the Krebs cycle. This is the urea cycle's handshake with energy metabolism. It's why urea cycle defects can affect overall metabolic function beyond just nitrogen. The cycles are physically connected through fumarate.

Deficiency: argininosuccinic acid spills into the urine. Boardable finding.
5
ArginaseLiver-specific. Cleaves arginine into urea + ornithine. Ornithine recycles back into mitochondria to continue the cycle.  · Arginase (liver only)
Arginine → Urea + Ornithine
The finish line. Urea is released into the blood, kidneys excrete it.

Ornithine re-enters the mitochondria and the cycle starts again. The cycle is complete.

Arginase deficiency is unique: it causes elevated arginine in blood and CSF. This leads to spastic diplegia and intellectual disability. Presentation is very different from the other defects (which cause encephalopathy in neonates). Arginase deficiency usually shows up later in childhood with neurologic findings.
Rate-limiting step: CPS I. Allosteric activator: N-acetylglutamate (NAG). The signal is: "amino acids are piling up, run the cycle."
🔂
The cycle spans TWO compartments. Steps 1-2 in mitochondria. Steps 3-5 in cytoplasm. Citrulline is the checkpoint that exits the mitochondria.
🔗
Fumarate connects urea cycle to Krebs cycle (step 4). This is the highest-yield cross-pathway connection on the clinical medicine. The cycles literally share a metabolite.

Where Does the Nitrogen Come From?

Urea is (NH2)2CO. Two nitrogen atoms. They come from two different places:

Nitrogen Source Enters Via Step
NH3 (free ammonia) CPS I in mitochondria Step 1
Aspartate Argininosuccinate Synthetase in cytoplasm Step 3

Glutamate is the primary donor of amino groups throughout the body. It donates to make both free ammonia (via glutamate dehydrogenase) and aspartate (via transamination). Everything feeds into these two entry points.

Urea Cycle Disorders

Any enzyme defect = ammonia can't exit = it builds up = brain swells. The question is WHICH defect.

Urea cycle pathway diagram highlighting the OTC enzyme step in the mitochondrion
📷 Neonatal presentation · tap to expand
OTC Deficiency
Ornithine Transcarbamylase Deficiency · Most Common
Inheritance
X-linked recessive · males severely affected, female carriers may have episodic symptoms after protein meals
Urine Finding
Elevated orotic acid · carbamoyl phosphate builds up, spills into pyrimidine pathway
Why Orotic Acid?
OTC is blocked → carbamoyl phosphate has nowhere to go → it leaks out of mitochondria into cytoplasm → feeds pyrimidine synthesis → orotic acid piles up
CPS I deficiency has NO elevated orotic acid. The bottleneck is before carbamoyl phosphate is even made.
Alzheimer type II astrocyte pathology in hepatic encephalopathy
📷 Brain pathology · tap to expand
CPS I Deficiency
Carbamoyl Phosphate Synthetase I Deficiency
Inheritance
Autosomal recessive · equally affects males and females
Urine Finding
Normal orotic acid · carbamoyl phosphate is never made, so there is nothing to spill
Clinical
Hyperammonemia, encephalopathy in neonates. Identical presentation to OTC clinically. The orotic acid level is the differentiator.
🔎
High ammonia + NO orotic acid = CPS I. High ammonia + orotic acid = OTC. That's the whole differential.
Urea cycle diagram showing the five enzymatic steps including the argininosuccinate lyase step
📷 Neonatal jaundice · tap to expand
AS Lyase Deficiency
Argininosuccinate Lyase Deficiency
Inheritance
Autosomal recessive
Pathognomonic Finding
Argininosuccinic acid in the urine · argininosuccinate accumulates because step 4 is blocked
Fumarate Connection
Fumarate is NOT generated → Krebs cycle is partially disconnected from urea cycle. Energy metabolism also impaired.
Neuropathology from nitrogen toxicity
📷 Neuropathology · tap to expand
Arginase Deficiency
Unique presentation · NOT neonatal encephalopathy
Inheritance
Autosomal recessive
What Accumulates
Elevated arginine in blood AND CSF · arginine is the direct precursor to urea, so it piles up at step 5
Clinical
Spastic diplegia + intellectual disability · progressive neurologic decline, presents in childhood NOT as a sick neonate
Arginase deficiency does NOT present as a sick neonate. It's a late-presenting progressive disease. clinical medicine love to use it as a trap in neonatal scenarios.

Differential at a Glance

Deficiency Inheritance NH3 Orotic Acid Pathognomonic Finding
OTC X-linked High HIGH Elevated orotic acid in urine
CPS I AR High Normal No orotic acid (bottleneck is pre-carbamoyl phosphate)
AS Lyase AR High Variable Argininosuccinic acid in urine
Arginase AR Mildly elevated Normal Elevated arginine, spastic diplegia in childhood
Board Trap #1: OTC vs CPS I
Both cause severe neonatal hyperammonemia. Both can present identically at the bedside. The ONLY lab that differentiates them is urine orotic acid. OTC: orotic acid HIGH (carbamoyl phosphate spills into pyrimidine synthesis). CPS I: orotic acid NORMAL (carbamoyl phosphate was never made).

Break it down: Orotic acid elevated = OTC. Full stop. If normal, think CPS I or organic acidemia.
Board Trap #2: NAG vs NAD vs NADH
clinical medicine try to trick you into writing "NAD" or "NADH" as the CPS I activator. It is N-acetylglutamate (NAG). They look similar, they abbreviate similarly, and the question stem will mention "cofactor" which makes you think coenzyme (NAD/NADH).

Break it down: NAG activates CPS I. NAD/NADH are redox cofactors for entirely different enzymes.
Board Trap #3: Where is Urea Made?
The urea cycle is in the liver only. Not muscle. Not kidney. The kidney excretes urea but does not synthesize it → the full cycle runs exclusively in hepatocytes. If a patient has liver failure, the urea cycle fails. clinical medicine love "which organ?" questions.

Break it down: Urea cycle = liver. Ammonia elevated in liver failure because this cycle stops working.
Board Trap #4: OTC is X-linked in a Disease about Protein
The question will describe a mother who "gets confused after eating protein" and has "episodic symptoms." That is a female OTC carrier. The disorder is X-linked, so males die as neonates and females survive as carriers with variable penetrance.

Break it down: Female + protein-induced encephalopathy = OTC carrier. Male neonate + hyperammonemia + orotic acid = OTC deficiency.

Clinical Presentation and Treatment

Every urea cycle defect causes hyperammonemia. The brain is the victim.

  Neonatal Hyperammonemia Presentation

These kids are fine at birth. Then mom starts breastfeeding (protein load). Within 24-72 hours, ammonia starts climbing.

Early
Lethargy, poor feeding, vomiting
Progressive
Irritability, abnormal tone, respiratory distress
Severe
Seizures, coma, cerebral edema, herniation
🧠
Ammonia is toxic to the brain because it causes cerebral edemaAmmonia crosses the blood-brain barrier, converts to glutamine in astrocytes. Glutamine accumulates and causes osmotic swelling (Alzheimer type II astrocytes on histology). This is why the brain CT shows diffuse edema.. Elevated ammonia also increases GABA effects, causing CNS depression. The brain swells. The child herniates.

  Treatment Ladder

  • First Line
    Low-protein diet · reduce the nitrogen load going into the cycle. Simple but essential. The Vmax of CPS I is the ceiling of the cycle. You can't run faster than that ceiling with less substrate.
  • Nitrogen Scavenging
    Sodium benzoate + sodium phenylacetate · these drugs provide alternative pathways for nitrogen excretion. Benzoate binds glycine (excreted as hippurate). Phenylacetate binds glutamine (excreted as phenylacetylglutamine). They bypass the broken urea cycle.
  • Arginine Supplementation
    Arginine supplementation · for all defects except arginase deficiency. The cycle can't make arginine when any upstream enzyme is blocked, so you supplement it. Keeps the cycle cycling as much as possible and supports protein synthesis.
  • GI Decontamination
    Neomycin + lactulose · gut bacteria make ammonia from protein via urease. Kill the bacteria (neomycin) and flush the gut (lactulose) to reduce ammonia production at its source. Used especially in hepatic encephalopathy from liver failure.
  • Definitive
    Liver transplant · the liver makes the cycle enzymes. Transplant replaces the broken factory with a working one. Cure for urea cycle defects except those with extrahepatic manifestations (arginase).

Derive It. Don't Memorize It.

Cover the answer. Work through it. Then reveal.

Why does OTC deficiency cause elevated orotic acid, but CPS I deficiency does NOT?
The logic chain:

1. Carbamoyl phosphate is made by CPS I in the mitochondria.
2. In OTC deficiency: CPS I works fine, carbamoyl phosphate IS made. But OTC is broken, so citrulline cannot be made. Carbamoyl phosphate builds up inside the mitochondria.
3. When carbamoyl phosphate accumulates, it leaks out of the mitochondria into the cytoplasm.
4. In the cytoplasm, carbamoyl phosphate feeds pyrimidine synthesis (carbamoyl phosphate → orotic acid pathway).
5. Result: orotic acid piles up and spills into the urine.

In CPS I deficiency: CPS I is broken. Carbamoyl phosphate is NEVER made. Nothing accumulates. No overspill into pyrimidines. Orotic acid stays normal.

The rule: elevated orotic acid requires carbamoyl phosphate to exist. OTC deficiency = yes. CPS I deficiency = never.
Why does high protein intake trigger symptoms in OTC carriers (female carriers of X-linked OTC deficiency)?
The logic chain:

Female OTC carriers have Lyon's hypothesis (X-inactivation) working against them. Some hepatocytes express the normal allele, some express the defective allele. Roughly 50% of liver cells have working OTC.

At baseline (low protein): the 50% working OTC is enough. Ammonia is cleared fine.

High protein meal: nitrogen load dramatically increases. The 50% working OTC maxes out. Ammonia starts accumulating. Symptoms appear.

This is why female OTC carriers present episodically after protein meals, not as sick neonates. The disease is the same. The dose of protein determines whether symptoms break through.

Board pattern: episodic confusion after high-protein meals in a female who had a sick male relative = OTC carrier. Always check family history.
You can name all 5 urea cycle enzymes from the substrates alone. Derive the names.
The enzymes are NAMED after what they do to their substrates:

1. CPS I: Synthesizes carbamoyl phosphate. (Carbamoyl Phosphate Synthetase)
2. OTC: Transfers the carbamoyl group to ornithine. (Ornithine Transcarbamoylase)
3. Argininosuccinate Synthetase: Makes argininosuccinate. (the "-ate" suffix = creates)
4. Argininosuccinate Lyase: Cleaves argininosuccinate. (lyase = cuts bonds without adding water)
5. Arginase: Cuts arginine.

If you know the substrates and products, you can reconstruct the enzyme names from etymology alone. This is derivation over memorization.

Board strategy: if you blank on an enzyme name, reason from substrate → product and work backward from naming conventions. It almost always works.

4 Patients Just Got Admitted

Results rotate from a pool of 10 original questions. Different quiz every visit.

Medically reviewed by Kaitlyn Cocuzzo, MD and Fatima Ali, DO · Last updated July 5, 2026 at 8:17 PM ET
Bone Wizardry is an independent educational resource for visual learning in the medical sciences. It is not affiliated with, endorsed by, or sponsored by any licensing or examination board, contains no real or recalled examination questions, and does not guarantee any educational or examination outcome.